SCHEMBL6147585

SCHEMBL6147585

CC1(C)CCSc2ccc(C(C=O)CCc3ccccc3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 9/20 0.40
RARB P10826 9/20 0.40
RARG P13631 9/20 0.40
RXRA P19793 4/20 0.40
SSTR5 P35346 1/20 0.35
CYP3A4 P08684 4/20 0.35
CYP26A1 O43174 4/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.33
CYP26B1 Q9NR63 3/20 0.32
RXRB P28702 1/20 0.32
CYP2D6 P10635 2/20 0.30
ADRB2 P07550 1/20 0.30
ADRB1 P08588 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
SLC6A2 P23975 1/20 0.30
ADRA1D P25100 1/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6143563 0.89 RARA (0.42) RARARARBRARGRXRASSTR5
SCHEMBL6147935 0.85 RXRA (0.44) RARARARBRARGRXRACYP3A4
SCHEMBL6147928 0.85 RXRA (0.44) RARARARBRARGRXRACYP3A4
SCHEMBL6145632 0.82 RARA (0.43) RARARARBRARGRXRASSTR5
SCHEMBL6147973 0.82 RARA (0.39) RARARARBRARGRXRASSTR5
SCHEMBL6147359 0.82 RARB (0.53) RARARARBRARGRXRASSTR5
SCHEMBL6148230 0.82 RARB (0.53) RARARARBRARGRXRASSTR5
SCHEMBL6147370 0.82 RARB (0.53) RARARARBRARGRXRASSTR5
SCHEMBL6143645 0.75 RARA (0.44) RARARARBRARGRXRASSTR5
SCHEMBL6146170 0.73 RARB (0.55) RARARARBRARGRXRASSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280757-B1 NEW GAMMA SELECTIVE RETINOIDS HOFFMANN LA ROCHE (CH) 2005-08-17 EP disclosed
US-6603012-B2 RAR selective retinoid agonists HOFFMANN-LA ROCHE INC. 2003-08-05 US disclosed
EP-1280757-A2 NEW GAMMA SELECTIVE RETINOIDS F. HOFFMANN-LA ROCHE AG (CH) 2003-02-05 EP disclosed
US-20020026060-A1 RAR selective retinoid agonists F.HOFFMANN-LA ROCHE AG (CH) 2002-02-28 US disclosed
WO-2001083438-A2 NEW GAMMA SELECTIVE RETINOIDS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020026060-A1 RAR selective retinoid agonists RARA, RARG, RARB RARA 1/4885RARB 3/4885RARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.